Molecular-guided decision-making improves disease control and remission in the treatment of IBD with anti-TNF therapy, however, application to other therapies is questioned.

Foresee Pharmaceuticals (TPEx: 6576) ("Foresee") announced today that it will actively participate in and Toby Maher, M.D., will deliver a keynote presentation titled "SyMMPonia: A Phase 2 Study of ...

TB-500, a synthetic version of a naturally occurring peptide called Thymosin Beta-4 (Tβ4), has gained significant attention ...

Objective Growing evidence suggests that coeliac disease (CeD) is more common in patients with inflammatory bowel disease ...

Living with inflammatory bowel disease (IBD) can be disruptive and painful. As the name implies, it affects your gastrointestinal (GI) tract, and the symptoms include, but are not limited to ...

A joint study between the University of Tennessee (Knoxville, Tennessee) and the University of Pennsylvania School of ...

“The prevalence of IBD continues to increase, and many people living with ulcerative colitis and Crohn’s disease do not respond to current therapies,” said Jonathon Sedgwick, AbbVie’s ...

The treatment landscape of Inflammatory Bowel Disease (IBD) has undergone a significant transformation over the past two decades. Historically, therapeutic strategies primarily focused on ...

Douglas Altshuler recently filed a federal complaint in California, alleging that Musk's firm discriminated against him due to his Crohn's disease Douglas Altshuler, a former employee of SpaceX ...

Major Cause of Inflammatory Bowel Disease Discovered June 5, 2024 — Researchers have discovered a new biological pathway that is a principal driver of inflammatory bowel disease (IBD ...

Diabetes is a condition that impairs the body’s ability to process blood glucose. There are several types, including type 1, type 2, and gestational diabetes. Each type requires a different ...